Literature DB >> 11072250

Adoptive transfer of human natural killer cells in mice with severe combined immunodeficiency inhibits growth of Hsp70-expressing tumors.

G Multhoff1, K Pfister, C Botzler, A Jordan, R Scholz, H Schmetzer, R Burgstahler, W Hiddemann.   

Abstract

In vitro, tumor-selective Hsp70 plasma membrane localization correlates with increased sensitivity to lysis mediated by a subpopulation of human natural killer (NK) cells that adhere to plastic following cytokine stimulation. In the present study, we analyzed the capacity of adoptively transferred human NK cells in SCID/beige mice for local tumor control and prevention of metastatic dissemination of Hsp70-expressing CX(+) and non-expressing CX(-) tumors following orthotopic (o.t.) injection. Both tumor sublines were derived by cell sorting of the original cell line, CX2, and thus exhibit an identical MHC and adhesion molecule expression pattern but differ with respect to Hsp70 plasma membrane expression. Viability of adherent, human NK cells in SCID/beige mice up to 18 days and the capacity to migrate have been demonstrated. Growth of Hsp70-expressing and non-expressing CX(+) and CX(-) tumor cells was completely suppressed when 10 x 10(6) NK cells were injected into the i.p. cavity on day 4 after inoculation of 2.5 x 10(6) tumor cells. Although a single injection of 5 or 2.5 x 10(6) NK cells was not sufficient to suppress tumor growth completely in all mice, the reduction in size of CX(+) tumors was significantly greater than that of CX(-) tumors. To mimic the clinical situation, ex vivo stimulated NK cells were injected i.v. on day 4 after o.t. injection of tumor cells. Under these conditions, growth of Hsp70-expressing primary tumors and metastases was suppressed. If CX(-) tumor cells were injected, 3 of 9 mice developed Hsp70-negative primary tumors. However, none of these mice developed distant metastases. In summary, our data indicate that Hsp70 acts as a recognition structure for adherent NK cells in a SCID/beige mouse model. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11072250     DOI: 10.1002/1097-0215(20001201)88:5<791::aid-ijc17>3.0.co;2-i

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  Serum level of soluble 70-kD heat shock protein is associated with high mortality in patients with colorectal cancer without distant metastasis.

Authors:  Judit Kocsis; Balázs Madaras; Eva Katalin Tóth; George Füst; Zoltán Prohászka
Journal:  Cell Stress Chaperones       Date:  2009-07-04       Impact factor: 3.667

Review 2.  [The role of radiotherapy in the induction of antitumor immune responses].

Authors:  G Multhoff; U S Gaipl; G Niedermann
Journal:  Strahlenther Onkol       Date:  2012-11       Impact factor: 3.621

3.  Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice.

Authors:  Erwin M Lee; Dean Yee; Samantha J Busfield; Julie F McManus; Nik Cummings; Gino Vairo; Andrew Wei; Hayley S Ramshaw; Jason A Powell; Angel F Lopez; Ian D Lewis; Martin N McCall; Richard B Lock
Journal:  Haematologica       Date:  2015-07       Impact factor: 9.941

4.  Humanization of a mouse monoclonal antibody directed against a cell surface-exposed epitope of membrane-associated heat shock protein 70 (Hsp70).

Authors:  Kirstin A Zettlitz; Julia Seitter; Dafne Müller; Roland E Kontermann
Journal:  Mol Biotechnol       Date:  2010-11       Impact factor: 2.695

Review 5.  The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells.

Authors:  Mathias Gehrmann; Jürgen Radons; Michael Molls; Gabriele Multhoff
Journal:  Cell Stress Chaperones       Date:  2008-02-05       Impact factor: 3.667

6.  Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells.

Authors:  Stefan Stangl; Catharina Gross; Alan G Pockley; Alexzander A Asea; Gabriele Multhoff
Journal:  Cell Stress Chaperones       Date:  2008-02-26       Impact factor: 3.667

7.  Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells.

Authors:  Christian Moser; Christin Schmidbauer; Ulrich Gürtler; Catharina Gross; Mathias Gehrmann; Gerald Thonigs; Karin Pfister; Gabriele Multhoff
Journal:  Cell Stress Chaperones       Date:  2002-10       Impact factor: 3.667

8.  Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy--a case report.

Authors:  Valeria Milani; Stefan Stangl; Rolf Issels; Mathias Gehrmann; Beate Wagner; Kathrin Hube; Doris Mayr; Wolfgang Hiddemann; Michael Molls; Gabriele Multhoff
Journal:  J Transl Med       Date:  2009-06-23       Impact factor: 5.531

9.  Chronic inflammation in cancer development.

Authors:  Gabriele Multhoff; Michael Molls; Jürgen Radons
Journal:  Front Immunol       Date:  2012-01-12       Impact factor: 7.561

10.  The complex function of hsp70 in metastatic cancer.

Authors:  Kata Juhasz; Anna-Maria Lipp; Benedikt Nimmervoll; Alois Sonnleitner; Jan Hesse; Thomas Haselgruebler; Zsolt Balogi
Journal:  Cancers (Basel)       Date:  2013-12-20       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.